Development of Murine Lupus Involves the Combined Genetic Contribution of the SLAM and FcgR Intervals within the Nba2 Autoimmune Susceptibility Locus
Artículo
Open/ Download
Publication date
2010Metadata
Show full item record
Cómo citar
Jørgensen, Trine N.
Cómo citar
Development of Murine Lupus Involves the Combined Genetic Contribution of the SLAM and FcgR Intervals within the Nba2 Autoimmune Susceptibility Locus
Author
- Jørgensen, Trine N.;
- Alfaro, Jennifer;
- Enríquez, Hilda L.;
- Jiang, Chao;
- Loo, William M.;
- Atencio, Stephanie;
- Bupp, Melanie R. Gubbels;
- Mailloux, Christina M.;
- Metzger, Troy;
- Flannery, Shannon;
- Rozzo, Stephen J.;
- Kotzin, Brian L.;
- Rosemblatt Silber, Mario César;
- Bono Merino, María Rosa;
- Erickson, Loren D.;
Abstract
Autoantibodies are of central importance in the pathogenesis of Ab-mediated autoimmune disorders. The murine lupus susceptibility
locus Nba2 on chromosome 1 and the syntenic human locus are associated with a loss ofimmune tolerance that leads to antinuclear Ab
production. To identify gene intervals within Nba2 that control the development of autoantibody-producing B cells and to determine
the cellular components through which Nba2 genes accomplish this, we generated congenic mice expressing various Nba2 intervals
where genes for the FcgR, SLAM, and IFN-inducible families are encoded. Analysis of congenic strains demonstrated that the FcgR
and SLAM intervals independently controlled the severity of autoantibody production and renal disease, yet are both required for
lupus susceptibility. Deregulated homeostasis of terminally differentiated B cells was found to be controlled by the FcgR interval
where FcgRIIb-mediated apoptosis of germinal center B cells and plasma cells was impaired. Increased numbers of activated
plasmacytoid dendritic cells that were distinctly CD19+ and promoted plasma cell differentiation via the proinflammatory cytokines
IL-10 and IFNa were linked to the SLAM interval. These findings suggest that SLAM and FcgR intervals act cooperatively to
influence the clinical course of disease through supporting the differentiation and survival of autoantibody-producing cells.
Patrocinador
This work is supported by grants from the Lupus Research Institute, Arthritis Foundation,
and National Institutes of Health Grant AR052902 to L.D.E., National Institutes
of Health Grant 5R01AR37070-19 to B.L.K., Fondecyt Grant 1060253 to M.
R., and Fondecyt Grant 1060834 and PFB 16 (Chile) to M.R.B.
Identifier
URI: https://repositorio.uchile.cl/handle/2250/119079
DOI: doi:10.4049/jimmunol.0901322
ISSN: 0022-1767 Print
Quote Item
The Journal of Immunology 2010;184: 775-786
Collections